Profil
Sahil V.
Kirpekar is currently President, Chief Executive Officer & Director at Reunion Neuroscience, Inc. since 2026.
Formerly, served as Director at IntelGenx Technologies Corp.
from 2023 to 2024, Chief Business Officer at Atai Beckley NV from 2022 to 2025, and Head-Business Development at Otsuka Pharmaceutical Co., Ltd. Education includes graduate studies at the University of Cambridge.
Postes actifs de Sahil Kirpekar
| Sociétés | Poste | Début |
|---|---|---|
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Directeur Général | 15/06/2026 |
Anciens postes connus de Sahil Kirpekar
| Sociétés | Poste | Fin |
|---|---|---|
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Corporate Officer/Principal | 02/04/2025 |
| INTELGENX TECHNOLOGIES CORP. | Directeur/Membre du Conseil | 17/05/2024 |
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and nutraceuticals | Corporate Officer/Principal | - |
Formation de Sahil Kirpekar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and nutraceuticals | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IntelGenx Technologies Corp.
IntelGenx Technologies Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops and manufactures oral film therapeutics | Health Technology |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
















